Vinay Prasad on COVID Boosters for Young, Healthy People: warns against

What Prasad says

Dr. Vinay Prasad warns against authorizing COVID-19 boosters for young, healthy people. It is a longstanding position: before joining the FDA, he criticized booster authorization for younger groups as unsupported by randomized evidence. As CBER director, he restricted COVID vaccine approvals to people 65+ and high-risk groups under his May 2025 framework with Commissioner Makary.

His stated reasoning

Prasad’s stated reasoning is that the randomized trial evidence does not show benefit for young, healthy recipients that would justify broad booster campaigns. Regulators, he says, should require large studies demonstrating benefit in each population before expanding authorization to it.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.